Please login to the form below

Why Facebook is not the solution to inclusive patient recruitment

With so many clinical trials underway to find an effective vaccine for COVID-19, the competition is rising. More and more organisations will be looking to recruit healthy volunteers, while ensuring inclusion and diversity in clinical trials, to complete their mission of finding a vaccine and making it available to the public as quickly as possible.

It’s understandable that many will turn to digital outreach as a solution to engage with so many people in a short space of time. What better way than reaching out to billions on Facebook, where so many people will see your ad for the clinical trial? Simple, right?

With 2 billion daily users, Facebook is one of the most powerful ways to reach patients. Plus, its wide reach, variety of ad types, and targeting options make it a promising tool for advertising clinical trials. However, a recent announcement from Facebook could hinder these benefits.

Facebook is limiting its targeting options

In August 2020, Facebook announced that they’ve been reviewing and refining their targeting options, to make it easier for advertisers to find and use targeting that will deliver the most value for businesses and people. And to streamline the options they provide, they’re removing options that are not widely used by advertisers.

As a result, they’ve taken the decision to withdraw the specific 'multicultural affinity’ targeting option, which used to be available in the US. This targeting option previously allowed marketers to reach users based on a ‘multicultural affinity’ for certain racial and ethnic groups, including African Americans and Hispanics.

For example, it allowed users to be solicited based on a category related to the data collected from their Facebook activity. Instead, Facebook are now encouraging advertisers to use other targeting options such as language or culture to reach people that are interested in multicultural content. While this targeting option may have been removed due to misuse, how might this affect patient recruitment that improves diversity in clinical trials? This shows that we cannot solely rely on digital outreach to engage with patients.

The power of patient insights

The industry needs to do more than just digital outreach to reach minorities, as digital alone will never be enough. There needs to be trust and relationships in place to truly build engagement. And that’s where community outreach and gaining patient insights comes in. By getting to know people and understanding their interests and their hobbies, we can circumnavigate the Facebook targeting changes. That’s not to say that Facebook ads are no longer effective – but we cannot solely rely on this approach. Study sponsors need to embrace community outreach and ensure they are engaging patients offline too.

At COUCH Health, we’re big advocates for improving diversity and inclusion in clinical trials. Find out more about how we can support you and your trial with this, such as through community outreach, at https://www.couchhealth.co/

This blog was first published here: https://www.couchhealth.co/post/why-facebook-is-not-the-solution-to-inclusive-patient-recruitment

2nd October 2020

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history.
COUCH Health
#DemandDiversity: The science behind diversity
We’re going back to the basics to explain why it’s so important for us to make a change.
COUCH Health
5 reasons clinical trial drop-out rates are on the rise
According to a recent report by the CSDD, patient recruitment rates have been steadily increasing, which is great news! The study found that 77% of clinical trials are now either meeting or exceeding their enrolment targets, in comparison to just 47% in 2012.
COUCH Health
#DemandDiversity: Names erased from history: A dive into black history of clinical research
You might be aware that February is Black History Month in the United States. So, we wanted to take the time to highlight some monumental moments and figures in the black history of clinical trials and medical research and share these with you
COUCH Health
How media portrayal of clinical trials can lead to underrepresentation
We knew that ethnic minority communities were being disproportionately affected by COVID-19, and we also knew that ethnic minorities were underrepresented in COVID-19 clinical trials. What we don’t know, however, is why ethnic minority groups weren’t taking part. So, we decided to do some digging.
COUCH Health
Can cultural safety training for sites improve diversity?
Through our Demand Diversity project, we’ve researched how the public is perceiving the industry during a time of heightened awareness, with a large focus on the perspectives of ethnic minority groups and key workers.
COUCH Health